These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
368 related items for PubMed ID: 17700342
1. Are standard instruments valid for the assessment of quality of life and symptoms in glaucoma? Lamoureux EL, Ferraro JG, Pallant JF, Pesudovs K, Rees G, Keeffe JE. Optom Vis Sci; 2007 Aug; 84(8):789-96. PubMed ID: 17700342 [Abstract] [Full Text] [Related]
2. Assessing participation in daily living and the effectiveness of rehabiliation in age related macular degeneration patients using the impact of vision impairment scale. Lamoureux EL, Pallant JF, Pesudovs K, Tennant A, Rees G, O'Connor PM, Keeffe JE. Ophthalmic Epidemiol; 2008 Aug; 15(2):105-13. PubMed ID: 18432494 [Abstract] [Full Text] [Related]
3. Development and validation of a vision-specific quality-of-life questionnaire for Timor-Leste. du Toit R, Palagyi A, Ramke J, Brian G, Lamoureux EL. Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4284-9. PubMed ID: 18502996 [Abstract] [Full Text] [Related]
4. The Impact of Vision Impairment Questionnaire: an evaluation of its measurement properties using Rasch analysis. Lamoureux EL, Pallant JF, Pesudovs K, Hassell JB, Keeffe JE. Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4732-41. PubMed ID: 17065481 [Abstract] [Full Text] [Related]
5. Validity of a visual impairment questionnaire in measuring cataract surgery outcomes. Pesudovs K, Caudle LE, Rees G, Lamoureux EL. J Cataract Refract Surg; 2008 Jun; 34(6):925-33. PubMed ID: 18498997 [Abstract] [Full Text] [Related]
6. Reengineering the glaucoma quality of life-15 questionnaire with rasch analysis. Khadka J, Pesudovs K, McAlinden C, Vogel M, Kernt M, Hirneiss C. Invest Ophthalmol Vis Sci; 2011 Sep 01; 52(9):6971-7. PubMed ID: 21810983 [Abstract] [Full Text] [Related]
7. Visual Activities Questionnaire: assessment of subscale validity for cataract surgery outcomes. Gothwal VK, Wright TA, Lamoureux EL, Pesudovs K. J Cataract Refract Surg; 2009 Nov 01; 35(11):1961-9. PubMed ID: 19878830 [Abstract] [Full Text] [Related]
8. Visual impairment, visual functioning, and quality of life assessments in patients with glaucoma. Parrish RK. Trans Am Ophthalmol Soc; 1996 Nov 01; 94():919-1028. PubMed ID: 8981717 [Abstract] [Full Text] [Related]
9. Can clinicians use the PHQ-9 to assess depression in people with vision loss? Lamoureux EL, Tee HW, Pesudovs K, Pallant JF, Keeffe JE, Rees G. Optom Vis Sci; 2009 Feb 01; 86(2):139-45. PubMed ID: 19156007 [Abstract] [Full Text] [Related]
10. An evaluation of the 10-item vision core measure 1 (VCM1) scale (the Core Module of the Vision-Related Quality of Life scale) using Rasch analysis. Lamoureux EL, Pesudovs K, Pallant JF, Rees G, Hassell JB, Caudle LE, Keeffe JE. Ophthalmic Epidemiol; 2008 Feb 01; 15(4):224-33. PubMed ID: 18780255 [Abstract] [Full Text] [Related]
11. Glaucoma and quality of life: the Salisbury Eye Evaluation. Freeman EE, Muñoz B, West SK, Jampel HD, Friedman DS. Ophthalmology; 2008 Feb 01; 115(2):233-8. PubMed ID: 17655930 [Abstract] [Full Text] [Related]
12. Rasch analysis of the quality of life and vision function questionnaire. Gothwal VK, Wright TA, Lamoureux EL, Pesudovs K. Optom Vis Sci; 2009 Jul 01; 86(7):E836-44. PubMed ID: 19521266 [Abstract] [Full Text] [Related]
13. Relationships in glaucoma patients between standard vision tests, quality of life, and ability to perform daily activities. Richman J, Lorenzana LL, Lankaranian D, Dugar J, Mayer JR, Wizov SS, Spaeth GL. Ophthalmic Epidemiol; 2010 Jun 01; 17(3):144-51. PubMed ID: 20455843 [Abstract] [Full Text] [Related]
14. The psychometric validity of the NEI VFQ-25 for use in a low-vision population. Marella M, Pesudovs K, Keeffe JE, O'Connor PM, Rees G, Lamoureux EL. Invest Ophthalmol Vis Sci; 2010 Jun 01; 51(6):2878-84. PubMed ID: 20089878 [Abstract] [Full Text] [Related]
15. Activities of Daily Vision Scale: what do the subscales measure? Gothwal VK, Wright TA, Lamoureux EL, Pesudovs K. Invest Ophthalmol Vis Sci; 2010 Feb 01; 51(2):694-700. PubMed ID: 19684011 [Abstract] [Full Text] [Related]
16. Assessment of the impact of vision impairment. Weih LM, Hassell JB, Keeffe J. Invest Ophthalmol Vis Sci; 2002 Apr 01; 43(4):927-35. PubMed ID: 11923230 [Abstract] [Full Text] [Related]
17. Depression and quality of life in patients with glaucoma: a cross-sectional analysis using the Geriatric Depression Scale-15, assessment of function related to vision, and the Glaucoma Quality of Life-15. Skalicky S, Goldberg I. J Glaucoma; 2008 Apr 01; 17(7):546-51. PubMed ID: 18854731 [Abstract] [Full Text] [Related]
18. The impact of vision impairment questionnaire: an assessment of its domain structure using confirmatory factor analysis and rasch analysis. Lamoureux EL, Pallant JF, Pesudovs K, Rees G, Hassell JB, Keeffe JE. Invest Ophthalmol Vis Sci; 2007 Mar 01; 48(3):1001-6. PubMed ID: 17325138 [Abstract] [Full Text] [Related]
19. Health- and vision-related quality of life in intellectually disabled children. Cui Y, Stapleton F, Suttle C, Bundy A. Optom Vis Sci; 2010 Jan 01; 87(1):37-44. PubMed ID: 19887968 [Abstract] [Full Text] [Related]
20. A self-assessment instrument designed for measuring independent mobility in RP patients: generalizability to glaucoma patients. Turano KA, Massof RW, Quigley HA. Invest Ophthalmol Vis Sci; 2002 Sep 01; 43(9):2874-81. PubMed ID: 12202505 [Abstract] [Full Text] [Related] Page: [Next] [New Search]